Compounds of formulas (I), (II), (III), and (IV) 1 and methods of treating disorders by administering a compound of formula (I), (II), (III), or (IV) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.

 
Web www.patentalert.com

< Anti-neurodegenerative agents

< Amide derivatives as kinase modulators

> Metabolites of (+)-(2S,3S)-3(2-methoxy-5- trifluoromethoxybenzylamino)-2-p- henyl-piperidine

> Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
~ 00222